eagle-i University of Hawaii at ManoaUniversity of Hawaii at Manoa
See it in Search
This page is a preview of the following resource. Continue onto eagle-i search using the button on the right to see the full record.

Licensing for Panc-WRN

eagle-i ID


Resource Type

  1. Access service


  1. Resource Description
    "A novel pancreatic ductal adenocarcinoma cell line with Werner RecQ helicase mutation has been created and was established from a patient with Werner Syndrome. WRN is an enzyme involved with DNA replication and repair and mutations of WRN predispose cells to premature aging, senescence, and oncologic transformation. WRN has been implicated as a tumor suppressor gene in recent literature. This is believed to be the first cancer cell line with mutant WRN, based on a review of current literature."
  2. Contact
    Park, Ann
  3. Service Provided by
    Office of Technology Transfer and Economic Development (OTTED)
  4. Website(s)
Provenance Metadata About This Resource Record
Copyright © 2016 by the President and Fellows of Harvard College
The eagle-i Consortium is supported by NIH Grant #5U24RR029825-02 / Copyright 2016